OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire
John F. Beausang, Aaron R. Wheeler, Natalie H. Chan, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 48
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
Nicholas Borcherding, Ajaykumar Vishwakarma, Andrew P. Voigt, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 245

Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger, Susannah G. Ellsworth, Moses Q. Wilks, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 12, pp. 729-745
Closed Access | Times Cited: 207

DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires
John-William Sidhom, H. Benjamin Larman, Drew M. Pardoll, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 188

Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer
Alice Tzeng, Naseer Sangwan, Margaret Jia, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 178

Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
Nicolás Gonzalo Núñez, Jimena Tosello, Rodrigo Nalio Ramos, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 155

The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer
Stephanie L. Goff, David N. Danforth
Clinical Breast Cancer (2020) Vol. 21, Iss. 1, pp. e63-e73
Open Access | Times Cited: 153

An integrated tumor, immune and microbiome atlas of colon cancer
Jessica Roelands, Peter J.K. Kuppen, Eiman I. Ahmed, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1273-1286
Open Access | Times Cited: 101

Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers
Hongyi Zhang, Longchao Liu, Jian Zhang, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 6, pp. 1359-1371
Open Access | Times Cited: 130

Antigen processing and presentation in cancer immunotherapy
Maxwell Lee, Jun W. Jeon, Cem Sievers, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001111-e001111
Open Access | Times Cited: 111

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A. Egelston, Christian Avalos, Travis Y. Tu, et al.
JCI Insight (2019) Vol. 4, Iss. 19
Open Access | Times Cited: 99

Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue
Jared Ostmeyer, Scott Christley, Inimary T. Toby, et al.
Cancer Research (2019) Vol. 79, Iss. 7, pp. 1671-1680
Open Access | Times Cited: 94

De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection
Daria Beshnova, Jianfeng Ye, Oreoluwa Onabolu, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 557
Open Access | Times Cited: 81

GIANA allows computationally-efficient TCR clustering and multi-disease repertoire classification by isometric transformation
Hongyi Zhang, Xiaowei Zhan, Bo Li
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 73

Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Andrea Aran, Laia Garrigós, Giuseppe Curigliano, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1771-1771
Open Access | Times Cited: 41

An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy
Xiangyu Chen, Jingxin Zhao, Shuai Yue, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 1063-1081
Open Access | Times Cited: 13

Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients
Jacky Chow, Nicholas C. Hoffend, Scott I. Abrams, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 38, pp. 23721-23729
Open Access | Times Cited: 58

Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids
Qingda Meng, Shanshan Xie, G. Kenneth Gray, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e003213-e003213
Open Access | Times Cited: 52

T-cell repertoire diversity: friend or foe for protective antitumor response?
Nicla Porciello, Ornella Franzese, Lorenzo D’Ambrosio, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 38

TCR-sequencing in cancer and autoimmunity: barcodes and beyond
Kristen E. Pauken, Kaitlyn A. Lagattuta, Benjamin Y. Lu, et al.
Trends in Immunology (2022) Vol. 43, Iss. 3, pp. 180-194
Open Access | Times Cited: 36

Self-supervised learning of T cell receptor sequences exposes core properties for T cell membership
Romi Goldner Kabeli, Sarit Zevin, Avital Abargel, et al.
Science Advances (2024) Vol. 10, Iss. 17
Open Access | Times Cited: 5

The Diagnostic, Prognostic, and Therapeutic Potential of Adaptive Immune Receptor Repertoire Profiling in Cancer
Lindsay G. Cowell
Cancer Research (2019) Vol. 80, Iss. 4, pp. 643-654
Open Access | Times Cited: 39

Using the T Cell Receptor as a Biomarker in Type 1 Diabetes
Maki Nakayama, Aaron W. Michels
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31

Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice
Jenna L. Collier, Kristen E. Pauken, Catherine Lee, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 10
Open Access | Times Cited: 12

Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade
Sara K. Daniel, Kevin M. Sullivan, Lindsay K. Dickerson, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top